Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Follicular granulosa cell apoptosis is a fundamental biological process characterized by the programmed cell death of granulosa cells within the ovarian follicle, primarily serving as the mechanism for follicular atresia [4, 11]. This process is tightly regulated by a balance of survival factors, such as follicle-stimulating hormone (FSH) and estrogen, and pro-apoptotic signals, including Caspase-3, BAX, and FoxO1 [6, 11, 13]. In a healthy ovary, more than 99% of follicles undergo atresia via this apoptotic pathway, ensuring that only a dominant follicle reaches ovulation in each cycle [12, 18]. Dysregulation of this process is a hallmark of major reproductive disorders: excessive apoptosis is a primary cause of premature ovarian failure (POF) and reproductive aging, while abnormally low levels of apoptosis contribute to the characteristic accumulation of small antral follicles in polycystic ovary syndrome (PCOS) [1, 6, 14]. Therapeutic interventions often target this pathway by utilizing gonadotropins (e.g., recombinant FSH) to promote survival signaling through the PI3K/Akt/mTOR pathway or by using antioxidants like resveratrol and vitamin E to mitigate oxidative stress-induced cell death [1, 10, 16]. Understanding and modulating granulosa cell apoptosis is therefore critical for managing infertility, enhancing the success of assisted reproductive technologies, and preserving ovarian function [2, 12, 13].
Modulation of the intrinsic and extrinsic apoptotic pathways via activation of survival signaling (PI3K/Akt/mTOR), inhibition of executioner caspases (Caspase-3), and transcriptional regulation of BCL-2 family proteins and FoxO1.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Follicular granulosa cell apoptosis.